Advertisement

Topics

Studies of US Lassa fever patient offer clues about immune response, viral persistence

20:00 EDT 21 Jun 2017 | AAAS

(Infectious Diseases Society of America) Researchers were able to closely study a Lassa fever patient's immune response over time after he was evacuated to the US for treatment.An experimental drug, favipiravir, was used in treating the US patient and an additional patient infected with Lassa virus in Germany. The drug appeared to have few serious side effects, but its efficacy is unknown.Individual patient reports cannot be generalized to broader population, but findings suggest promising areas for future research.

Original Article: Studies of US Lassa fever patient offer clues about immune response, viral persistence

NEXT ARTICLE

More From BioPortfolio on "Studies of US Lassa fever patient offer clues about immune response, viral persistence"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...